Author

Zhongfeng Dang

Observed names: Dang, Zhongfeng, 党中峰

Institution: Qinghai Red Cross Hospital

Observed institution: Qinghai Red Cross Hospital

ORCID: 0009-0007-2196-8183

Observed ORCID: 0009-0007-2196-8183

OpenAlex ID: A5108855484

Effect of bevacizumab administered prior to transarterial chemoembolization on the therapeutic effects of lenvatinib given post-TACE in primary liver cancer patients

2023 · Zhongfeng Dang, Liwen Jiang, et al. · International Journal of Clinical Pharmacology and Therapeutics · 3

The Plateau Hemoglobin Paradox: Reversed Effect of Hemoglobin on Surgical Outcomes by Oxygen Saturation Strata at High Altitude

2026 · Zhongfeng Dang, Jianduojie Dan, et al. · medRxiv · 1

Cost Homogenization and System-Level Drivers in Plateau Laparoscopic Cholecystectomy: Failure and Reconstruction of Traditional Cost-Control Models in the DRG Era

2026 · Zhongfeng Dang, Guoliang Ren, et al. · medRxiv · 1

Clinical Epidemiological Features and Risk Factor Weight Remodeling in Gallstone Patients on the Plateau

2026 · Zhiqiang Wang, Guoliang Ren, et al. · medRxiv · 1

EPAS1 Adaptive Loss-of-Function Variants as Germline Determinants of Primary Antiangiogenic TKI Resistance in High-Altitude Hepatocellular Carcinoma

2026 · Zhongfeng Dang, Junlin Gao, et al. · medRxiv · 1

SG-FP01 source analysis: calibration of gemcitabine pharmacovigilance signals (FAERS)

2026 · Dang, Zhongfeng, Ren, Guoliang, et al. · Zenodo (CERN European Organization for Nuclear Research)

Extreme-Population Pharmacology as a Natural Stress-Test for Drug Safety: The Sentinel-Case Causal-Inference (DABR/FOCUS) Framework

2026 · Zhongfeng Dang, Guoliang Ren, et al. · Preprints.org

DABR/FOCUS Blank Templates: Reporting Checklist (Table 4) and DABR Audit-Log Template

2026 · 党中峰, 任国亮, et al. · ScienceDB

PAERS study — analysis code for four high-altitude laparoscopic cholecystectomy analyses

2026 · Zhongfeng Dang, Junlin Gao, et al. · ScienceDB

Fatal "Local Repair, Global Collapse" Paradox Associated with a LALA-Fc PD-1/VEGF Bispecific Antibody (Ivonescimab) in a High-Altitude Tibetan Patient with Hepatocellular Carcinoma: A Sentinel Case Report

2026 · Zhongfeng Dang, Guoliang Ren, et al. · Preprints.org

Reporting Odds Ratio Analysis of Gemcitabine-Based Chemotherapy Regimens for Biliary and Pancreatic Cancer: Population-Level Toxicity Signals and Hypotheses for High-Altitude Generalizability

2026 · Zhongfeng Dang, Jianduojie Dan, et al. · medRxiv

Patient-Specific Adaptations in ERAS for High-Altitude Laparoscopic Cholecystectomy: The PAERS Hypothesis

2026 · Zhongfeng Dang, Jianduojie Dan, et al. · medRxiv

Operative Time Heterogeneity in Laparoscopic Cholecystectomy at High Altitude: Surgeon Variability as a Modifiable Factor under Hypoxic Stress

2026 · Guoliang Ren, Zhiqiang Wang, et al. · medRxiv

A Multi-stage Precision Stratification (MPS) Framework for Navigating Adjuvant Immunotherapy in Hepatocellular Carcinoma After Resection

2026 · Zhongfeng Dang, Jianduojie Dan, et al. · medRxiv

Therapeutically targeting autophagy enhances cytotoxicity of emodin in liver cancer cell lines

2017 · 党中峰, 何科基, et al. · DOAJ (DOAJ: Directory of Open Access Journals)

Works count: 15

Citation count: 7

H-index: 1

I10-index: